Marinus Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.89 | -$0.53 | -$0.66 |
| Q2 2024 | 4 | -$0.79 | -$0.48 | -$0.59 |
| Q3 2024 | 1 | -$0.55 | -$0.33 | -$0.41 |
| Q4 2024 | 3 | -$0.36 | -$0.21 | -$0.29 |
| Q1 2025 | 2 | -$0.32 | -$0.07 | -$0.21 |
| Q2 2025 | 1 | -$0.24 | -$0.15 | -$0.18 |
| Q3 2025 | 1 | -$0.20 | -$0.12 | -$0.15 |
| Q4 2025 | 1 | -$0.16 | -$0.09 | -$0.12 |
| Q1 2026 | 1 | -$0.11 | -$0.06 | -$0.08 |
| Q2 2026 | 1 | -$0.09 | -$0.05 | -$0.07 |
| Q3 2026 | 1 | -$0.11 | -$0.06 | -$0.08 |
| Q4 2026 | 1 | -$0.13 | -$0.08 | -$0.10 |
| Q1 2027 | 1 | $0.07 | $0.11 | $0.08 |
| Q2 2027 | 1 | $0.08 | $0.13 | $0.10 |
| Q3 2027 | 1 | $0.07 | $0.11 | $0.08 |
| Q4 2027 | 1 | $0.06 | $0.10 | $0.08 |
| Q1 2028 | 1 | $0.19 | $0.31 | $0.23 |
| Q2 2028 | 1 | $0.51 | $0.85 | $0.63 |
| Q3 2028 | 1 | $0.49 | $0.81 | $0.61 |
| Q4 2028 | 1 | $0.49 | $0.81 | $0.60 |
Marinus Pharmaceuticals, Inc. Earnings Date And Information
Marinus Pharmaceuticals, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.6 earnings per share for the quarter, missing analysts' consensus estimates of $-0.59 by $0.01. The company had revenue of 8.47 M for the quarter and had revenue of 30.99 M for the year. Marinus Pharmaceuticals, Inc. has generated $-3 earnings per share over the last year ($-2.63 diluted earnings per share) and currently has a price-to-earnings ratio of -0.13. Marinus Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Marinus Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.42 | $9.42 M | $8.47 M | ||
| 08/13/2024 | Q2 2024 | -$0.59 | -$0.63 | -0.04 | $9.58 M | $8.06 M |
| 05/08/2024 | Q1 2024 | -$0.68 | -$0.68 | 0 | $7.68 M | |
| 03/05/2024 | Q4 2023 | -$0.64 | -$0.74 | -0.1 | $7.19 M | |
| 11/07/2023 | Q3 2023 | -$0.67 | -$0.61 | 0.06 | $6.32 M | $7.34 M |
| 08/10/2023 | Q2 2023 | -$0.76 | -$0.61 | 0.15 | $5.73 M | $6.08 M |
| 05/11/2023 | Q1 2023 | -$0.77 | -$0.67 | 0.1 | $10.38 M | |
| 03/09/2023 | Q4 2022 | -$0.76 | $7.16 M | |||
| 11/07/2022 | Q3 2022 | $0.25 | $1.93 | 1.68 | $25.76 M | $2.34 M |
| 08/11/2022 | Q2 2022 | -$0.93 | -$1.06 | -0.13 | $2.28 M | $1.79 M |
| 05/12/2022 | Q1 2022 | -$0.87 | -$0.57 | 0.3 | $14.19 M | |
| 03/24/2022 | Q4 2021 | -$0.77 | $1.52 M | |||
| 11/09/2021 | Q3 2021 | -$0.76 | -$0.53 | 0.23 | $5.16 M | $10.11 M |
| 08/10/2021 | Q2 2021 | -$0.68 | -$0.65 | 0.03 | $2.63 M | $1.91 M |
| 05/17/2021 | Q1 2021 | -$0.46 | -$0.74 | -0.28 | $1.81 M | |
| 03/09/2021 | Q4 2020 | -$0.55 | $1.55 M | |||
| 11/09/2020 | Q3 2020 | -$0.62 | -$0.51 | 0.11 | $478,125 | $171,000 |
| 08/06/2020 | Q2 2020 | -$0.76 | -$0.63 | 0.13 | $0 | |
| 05/04/2020 | Q1 2020 | -$0.60 | -$0.86 | -0.26 | $0 | |
| 03/16/2020 | Q4 2019 | -$0.71 | $0 |
Marinus Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Marinus Pharmaceuticals, Inc.'s earnings date?
Marinus Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
How can I listen to Marinus Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Marinus Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Marinus Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Marinus Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Marinus Pharmaceuticals, Inc. generate each year?
Marinus Pharmaceuticals, Inc. (:MRNS) has a recorded annual revenue of $30.99 M.
-
How much profit does Marinus Pharmaceuticals, Inc. generate each year?
Marinus Pharmaceuticals, Inc. (:MRNS) has a recorded net income of $30.99 M. Marinus Pharmaceuticals, Inc. has generated $-2.63 earnings per share over the last four quarters.
-
What is Marinus Pharmaceuticals, Inc.'s price-to-earnings ratio?
Marinus Pharmaceuticals, Inc. (:MRNS) has a price-to-earnings ratio of -0.13 and price/earnings-to-growth ratio is -0.02.
